Perrigo (PRGO) Long-Term Investments (2013 - 2020)
Perrigo's (PRGO) quarterly Long-Term Investments came in at $121.2 million in Q3 2020, up 32.17% year-on-year from $91.7 million in Q3 2019, and up 22.42% on a QoQ basis from $99.0 million in Q2 2020.
Perrigo (PRGO) Long-Term Investments (2013 - 2020) Analysis & Trends
Perrigo (PRGO) has 7 years of Long-Term Investments data on file, last reported at $121.2 million in Q3 2020.
- On a quarterly basis, Long-Term Investments rose 32.17% year-over-year to $121.2 million in Q3 2020; TTM through Sep 2020 was $121.2 million, a 32.17% increase from a year earlier, with the FY2019 full-year figure at $95.3 million, down 70.51% from the prior year.
- Long-Term Investments for Q3 2020 stood at $121.2 million, up from $99.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for PRGO reached as high as $3.6 billion in Q2 2016 and fell as low as $83.6 million in Q1 2019.
- Historically, Long-Term Investments has averaged $364.4 million across 5 years, with a median of $124.9 million in 2018.
- Across the five-year window, Long-Term Investments tumbled 94.8% in 2017 and soared 140.3% in 2018, its largest moves.
- Year by year, Long-Term Investments stood at $3.6 billion in 2016, then sank by 96.21% to $134.5 million in 2017, then surged by 140.3% to $323.2 million in 2018, then slumped by 70.51% to $95.3 million in 2019, then grew by 27.18% to $121.2 million in 2020.
- Per Business Quant data, the three most recent Long-Term Investments figures were $121.2 million in Q3 2020, $99.0 million in Q2 2020, and $96.9 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 26, 2020 | 121.20 Mn |
| Jun 27, 2020 | 99.00 Mn |
| Mar 28, 2020 | 96.90 Mn |
| Dec 31, 2019 | 95.30 Mn |
| Sep 28, 2019 | 91.70 Mn |
| Jun 29, 2019 | 89.10 Mn |
| Mar 30, 2019 | 83.60 Mn |
| Dec 31, 2018 | 323.20 Mn |
| Sep 29, 2018 | 200.40 Mn |
| Jun 30, 2018 | 125.50 Mn |
| Mar 31, 2018 | 124.90 Mn |
| Dec 31, 2017 | 134.50 Mn |
| Jul 1, 2017 | 145.80 Mn |
| Apr 1, 2017 | 184.50 Mn |
| Apr 2, 2016 | 3.55 Bn |
| Mar 29, 2014 | 60.60 Mn |
| Dec 28, 2013 | 69.00 Mn |
| Jun 29, 2013 | 4.40 Mn |